Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Safety and antitumor activity of BMS-754807 reported in phase I trial

July 7, 2010

Cell Therapeutics files updated Pediatric Investigation Plan for pixantrone to the EMA

July 6, 2010

ADVENTRX reports encouraging 9-month data from stability tests of Exelbine

July 6, 2010

Myriad Pharmaceuticals changes name to Myrexis, will focus on oncology programs

July 6, 2010

Maximum tolerated dose of acadesine identified in chronic lymphocytic leukemia patients

July 6, 2010

Multikinase inhibitor regorafenib evaluated in NSCLC; interim phase I data presented

July 6, 2010

Bruton's tyrosine kinase inhibitors reported by CGI and Genentech

July 6, 2010

Phase III study of Avastin combined with chemotherapy meets primary endpoint

July 5, 2010

FDA grants Cyclacel orphan designation for sapacitabine in AML and MDS

July 5, 2010

Banyu discovers Wee1 kinase inhibitors for cancer therapy

July 5, 2010

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...